Biomind Labs Inc.
BMND
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -104.10K | -564.30K | -102.80K | -116.50K | -66.80K |
| Total Depreciation and Amortization | -- | 0.00 | 0.00 | 0.00 | 2.20K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 23.90K | 467.50K | 15.80K | 24.00K | -48.40K |
| Change in Net Operating Assets | 14.30K | 47.90K | 48.30K | 112.20K | 113.40K |
| Cash from Operations | -66.00K | -49.00K | -38.70K | 19.70K | 500.00 |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 71.00K | 21.00K | 65.00K | 400.00 | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 71.00K | 21.00K | 65.00K | 400.00 | -- |
| Foreign Exchange rate Adjustments | 9.40K | -8.70K | 10.20K | -19.90K | -500.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 14.40K | -36.70K | 36.50K | 100.00 | 0.00 |